- Home
- LMFA vs PHGE Comparison
LMFA vs PHGE Comparison
Compare LMFA & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- PHGE
- Stock Information
- Founded
- LMFA 2008
- PHGE 2015
- Country
- LMFA United States
- PHGE Israel
- Employees
- LMFA N/A
- PHGE N/A
- Industry
- LMFA Finance: Consumer Services
- PHGE Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- PHGE Health Care
- Exchange
- LMFA Nasdaq
- PHGE Nasdaq
- Market Cap
- LMFA 11.9M
- PHGE 10.4M
- IPO Year
- LMFA 2015
- PHGE N/A
- Fundamental
- Price
- LMFA $2.38
- PHGE $0.50
- Analyst Decision
- LMFA Hold
- PHGE Strong Buy
- Analyst Count
- LMFA 1
- PHGE 1
- Target Price
- LMFA N/A
- PHGE $15.00
- AVG Volume (30 Days)
- LMFA 2.8M
- PHGE 12.4M
- Earning Date
- LMFA 08-14-2025
- PHGE 08-13-2025
- Dividend Yield
- LMFA N/A
- PHGE N/A
- EPS Growth
- LMFA N/A
- PHGE N/A
- EPS
- LMFA N/A
- PHGE N/A
- Revenue
- LMFA $8,029,601.00
- PHGE N/A
- Revenue This Year
- LMFA $0.98
- PHGE N/A
- Revenue Next Year
- LMFA $4.31
- PHGE N/A
- P/E Ratio
- LMFA N/A
- PHGE N/A
- Revenue Growth
- LMFA N/A
- PHGE N/A
- 52 Week Low
- LMFA $1.02
- PHGE $0.34
- 52 Week High
- LMFA $5.14
- PHGE $1.91
- Technical
- Relative Strength Index (RSI)
- LMFA 49.72
- PHGE 52.41
- Support Level
- LMFA $1.87
- PHGE $0.45
- Resistance Level
- LMFA $2.52
- PHGE $0.72
- Average True Range (ATR)
- LMFA 0.28
- PHGE 0.07
- MACD
- LMFA -0.02
- PHGE 0.01
- Stochastic Oscillator
- LMFA 38.69
- PHGE 34.49
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).